Jan Köster
Impact in
- Genetics top 0.05%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Rogier Versteeg (66 shared papers)Jan J. Molenaar (35 shared papers)Peter V. Sluis (16 shared papers)Huib N. Caron (22 shared papers)Dirk Geerts (18 shared papers)Arnoud Sonnenberg (10 shared papers)Richard Volckmann (14 shared papers)Linda J. Valentijn (11 shared papers)
- Journals
- Nature (11 papers)European Journal of Cancer (11 papers)Cancer Cell (11 papers)International Journal of Cancer (10 papers)PLoS ONE (9 papers)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Jan Köster
243 papers receiving 26.6k citations
Jan Köster's Hit Papers
Peers
Comparison fields: 5 of 147
- Genetics 7.1k
- Cancer Research 3.4k
- Neurology 3.5k
- Oncology 3.6k
- Molecular Biology 7.7k
Countries citing papers authored by Jan Köster
This map shows the geographic impact of Jan Köster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Köster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Köster more than expected).
Fields of papers citing papers by Jan Köster
This network shows the impact of papers produced by Jan Köster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Köster. The network helps show where Jan Köster may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Köster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 249 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients Hit paper breakdown → | 2015 | 1953 |
| 2 | Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma Hit paper breakdown → | 2012 | 1522 |
| 3 | The landscape of genomic alterations across childhood cancers Hit paper breakdown → | 2018 | 1176 |
| 4 | Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups Hit paper breakdown → | 2015 | 915 |
| 5 | The whole-genome landscape of medulloblastoma subtypes Hit paper breakdown → | 2017 | 852 |
| 6 | Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas Hit paper breakdown → | 2012 | 808 |
| 7 | RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics Hit paper breakdown → | 2015 | 740 |
| 8 | Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes Hit paper breakdown → | 2012 | 729 |
| 9 | New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs Hit paper breakdown → | 2016 | 728 |
| 10 | Dissecting the genomic complexity underlying medulloblastoma Hit paper breakdown → | 2012 | 705 |
| 11 | Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations Hit paper breakdown → | 2012 | 693 |
| 12 | Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma Hit paper breakdown → | 2013 | 659 |
| 13 | The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers Hit paper breakdown → | 2012 | 635 |
| 14 | Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition Hit paper breakdown → | 2014 | 624 |
| 15 | 2008 | 585 | |
| 16 | Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma Hit paper breakdown → | 2014 | 520 |
| 17 | Epigenomic alterations define lethal CIMP-positive ependymomas of infancy Hit paper breakdown → | 2014 | 492 |
| 18 | 2016 | 442 | |
| 19 | 2013 | 440 | |
| 20 | Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations Hit paper breakdown → | 2015 | 436 |
About Jan Köster
Jan Köster is a scholar working on Neurology, Genetics, Cancer Research, Oncology and Molecular Biology, having authored 249 papers that have together received 27k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (95 papers), Glioma Diagnosis and Treatment (34 papers), Cancer Genomics and Diagnostics (16 papers), Cancer Cells and Metastasis (14 papers), Colorectal Cancer Treatments and Studies (10 papers), Skin and Cellular Biology Research (8 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Wnt/β-catenin signaling in development and cancer (7 papers). The work is most often cited by research in Genetics (7.1k citations), Cancer Research (3.4k citations), Neurology (3.5k citations), Oncology (3.6k citations) and Molecular Biology (7.7k citations). Jan Köster has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Rogier Versteeg, Jan J. Molenaar, Peter V. Sluis, Huib N. Caron, Dirk Geerts, Arnoud Sonnenberg, Richard Volckmann, Linda J. Valentijn, Nancy E. Hasselt and Danny A. Zwijnenburg. Their work appears in journals such as Nature, European Journal of Cancer, Cancer Cell, International Journal of Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.